ADPTAdaptive Biotechnologies Corp同业对比
Adaptive Biotechnologies Corp 与SIC 2836 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ADPT本股 | $4.4B#8 | — | 30.9x#11 | 16.0x#3 | 54.8%#7 | 62.7%#3 | -20.6%#3 | -41.6%#6 | — | — | 114.7%#5 | — |
| PCVX | $8.7B#1 | — | 3.2x#4 | — | — | -65.2%#11 | — | -0.0%#1 | — | — | 88.2%#7 | — |
| IBRX | $8.4B#2 | — | — | 74.1x#6 | 668.3%#1 | 15.0%#5 | -226.0%#5 | — | — | — | 182.4%#3 | — |
| IMVT | $7.5B#3 | — | 10.2x#9 | — | — | -22.2%#8 | — | -68.8%#10 | — | — | 138.2%#4 | — |
| CGON | $6.6B#4 | — | 6.4x#7 | 1627.1x#8 | 254.7%#2 | -82.9%#12 | -4722.1%#7 | -15.6%#3 | -18.8%#1 | — | 107.2%#6 | — |
| SRRK | $6.0B#5 | — | 23.7x#10 | — | — | -53.7%#9 | — | -148.9%#11 | -2854.7%#5 | — | 52.7%#9 | — |
| CRSP | $5.0B#6 | — | 2.9x#3 | 1438.0x#7 | -90.6%#8 | -58.8%#10 | -18933.6%#8 | -33.3%#5 | -32.6%#2 | — | -14.6%#13 | — |
| IOVA | $4.5B#7 | — | 6.1x#6 | 17.0x#4 | 60.6%#6 | -5.1%#6 | -153.1%#4 | -53.1%#8 | — | — | 329.3%#2 | — |
| TARS | $3.4B#9 | — | 9.8x#8 | 7.5x#2 | 146.7%#3 | 43.1%#4 | -15.7%#2 | -19.0%#4 | -33.0%#3 | — | 53.5%#8 | — |
| DNLI | $3.2B#10 | — | 3.8x#5 | — | — | -21.2%#7 | — | -61.4%#9 | — | — | 51.5%#10 | — |
| RVMDW | $2.8B#11 | — | 1.1x#1 | — | — | -88.5%#13 | — | -43.4%#7 | — | — | 4197.3%#1 | — |
| BEAM | $2.4B#12 | — | 2.2x#2 | 17.1x#5 | 120.0%#4 | 78.8%#2 | -274.6%#6 | -7.5%#2 | -40.5%#4 | — | 0.9%#12 | — |
| BCRX | $2.2B#13 | — | — | 2.5x#1 | 94.1%#5 | 396.9%#1 | 39.0%#1 | — | — | — | 9.2%#11 | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-09-17。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议